Logo image of DNA

GINKGO BIOWORKS HOLDINGS INC (DNA) Stock Analyst Earnings Estimates

NYSE:DNA - New York Stock Exchange, Inc. - US37611X2099 - Common Stock - Currency: USD

13.46  -0.5 (-3.58%)

After market: 13.46 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
DNA revenue by date.DNA revenue by date.
477.7M
52.23%
251.455M
-47.36%
227.043M
-9.71%
179.99M
-20.72%
208.62M
15.91%
225.7M
8.19%
1.137B
403.77%
1.557B
36.94%
2.115B
35.84%
EBITDA
YoY % growth
DNA ebitda by date.DNA ebitda by date.
-2.12B
-17.83%
-505.514M
76.16%
-420.29M
16.86%
-208.508M
50.39%
-111.708M
46.43%
-163.641M
-46.49%
1.186B
824.76%
1.951B
64.50%
2.176B
11.53%
EBIT
YoY % growth
DNA ebit by date.DNA ebit by date.
-2.163B
-18.28%
-576.021M
73.37%
-483.31M
16.10%
-354.754M
26.60%
-250.486M
29.39%
-236.113M
5.74%
N/AN/AN/A
Operating Margin
DNA operating margin by date.DNA operating margin by date.
-452.75%-229.08%-212.87%-197.10%-120.07%-104.61%N/AN/AN/A
EPS
YoY % growth
DNA eps by date.DNA eps by date.
-49.20
-512.86%
-18.80
61.79%
-8.94
52.45%
-6.19
30.78%
-4.91
20.73%
-3.27
33.29%
-0.10
96.91%
-0.01
90.00%
0.10
1,100.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.45
-54.37%
-1.46
26.94%
-1.59
5.61%
-2.12
-92.82%
-1.98
-36.43%
-1.89
-29.26%
Revenue
Q2Q % growth
44.369M
-50.17%
44.796M
2.16%
45.773M
-5.27%
55.197M
11.28%
60.499M
36.35%
62.267M
39.00%
EBITDA
Q2Q % growth
-40.626M
-614.86%
-40.69M
-6.74%
-41.91M
39.48%
-25.957M
49.59%
-20.099M
50.53%
-19.796M
51.35%
EBIT
Q2Q % growth
-77.72M
-46.50%
-80.325M
20.58%
-85.244M
-0.75%
-55.55M
42.13%
-37.774M
51.40%
-33.936M
57.75%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-1.10
60.71%
-1.580.4830.48%
Q1 2025
Q2Q % growth
-1.68
47.50%
-1.790.116.02%
Q4 2024
Q2Q % growth
-2.00
54.55%
-1.79-0.21-11.88%
Q3 2024
Q2Q % growth
-0.94
85.31%
-2.751.8165.88%
Q2 2024
Q2Q % growth
-2.80
22.22%
-3.150.3511.14%
Q1 2024
Q2Q % growth
-3.20
27.27%
-3.370.174.95%
Q4 2023
Q2Q % growth
-4.40
-22.22%
-3.91-0.49-12.66%
Q3 2023
Q2Q % growth
-6.40
60.98%
-3.46-2.94-84.83%
Q2 2023
Q2Q % growth
-3.60
79.07%
-3.41-0.19-5.72%
Q1 2023
Q2Q % growth
-4.40
63.33%
-3.64-0.76-21.01%
Q4 2022
Q2Q % growth
-3.60
90.91%
-8.434.8357.28%
Q3 2022
Q2Q % growth
-16.40
-583.33%
-11.96-4.44-37.14%
Q2 2022
Q2Q % growth
-17.20 -1.75-15.45-882.56%
Q1 2022
Q2Q % growth
-12.00 -1.35-10.65-791.18%
Q4 2021
Q2Q % growth
-39.60 -1.75-37.85-2,162.17%
Q3 2021
Q2Q % growth
-2.40 -1.41-0.99-69.73%
DNA Yearly EPS VS EstimatesDNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30 -40 -50
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
49.6M
-11.75%
42.026M7.574M18.02%
Q1 2025
Q2Q % growth
48.318M
27.34%
39.083M9.235M23.63%
Q4 2024
Q2Q % growth
43.847M
26.16%
44.909M-1.062M-2.36%
Q3 2024
Q2Q % growth
89.046M
60.65%
45.45M43.596M95.92%
Q2 2024
Q2Q % growth
56.206M
-30.24%
43.568M12.638M29.01%
Q1 2024
Q2Q % growth
37.944M
-52.98%
46.504M-8.56M-18.41%
Q4 2023
Q2Q % growth
34.755M
-64.64%
42.927M-8.172M-19.04%
Q3 2023
Q2Q % growth
55.43M
-16.52%
48.557M6.873M14.15%
Q2 2023
Q2Q % growth
80.568M
-44.28%
72.296M8.272M11.44%
Q1 2023
Q2Q % growth
80.702M
-52.08%
72.397M8.305M11.47%
Q4 2022
Q2Q % growth
98.3M
-33.80%
89.547M8.753M9.77%
Q3 2022
Q2Q % growth
66.4M
-14.43%
60.959M5.441M8.93%
Q2 2022
Q2Q % growth
144.6M
231.65%
78.402M66.198M84.43%
Q1 2022
Q2Q % growth
168.4M
281.86%
106.74M61.66M57.77%
Q4 2021
Q2Q % growth
148.5M
362.62%
95.755M52.745M55.08%
Q3 2021
Q2Q % growth
77.6M
483.46%
46.208M31.392M67.94%
DNA Yearly Revenue VS EstimatesDNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 4.91% 0% 0.05%
Revenue0% -4.6% -0.09% 2.99%